Vesynta

Sutton, United Kingdom

Clinical Decision Support Pharmacotherapy Interoperability Clinical Workflow

Vesynta is a healthcare startup focused on data-guided precision dosing to enhance health equity and therapeutic outcomes. The company offers a digital dosing co-pilot that provides patient-centric recommendations and interpretable dosing insights, empowering clinical decision-making through best-practice pharmacology modeling. Their platform integrates seamlessly with prominent electronic health record systems to ensure minimal disruption to clinical workflows while maintaining secure data utilization at the point of care. Vesynta aims to optimize drug dosing through individualized treatment regimens, reducing the risk of adverse effects and increasing the likelihood of achieving targeted therapeutic levels. The company's approach addresses variability in drug exposure and aims to improve the quality of life for patients, particularly within underrepresented populations. Their platform is backed by experts in clinical oncology and is designed to maximize the effectiveness of treatments while minimizing side effects.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Vesynta on @MedStartr Today #PersonalizedMedicine #GeneralPatientCareAndWellness #ClinicalDecisionSupport #Pharmacotherapy #Interoperability #ClinicalWorkflow #MedMo #MedStartrVentures

https://www.medstartr.ai/s/p9xJEPffcCk

Get Involved in Vesynta

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2019
Website: www.vesynta.com/

Disease Areas

Personalized Medicine General Patient Care and Wellness

Technologies

Clinical Decision SupportEHR IntegrationPharmacology Platforms

🌐Website

What do you think of Vesynta?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.